Wells Fargo
INAB icon

Wells Fargo’s IN8bio INAB Stock Holding History

Wells Fargo’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8
Closed -$291 – 7157
2024
Q1 		$291 Buy
8
+3
+60% +$113 ﹤0.01% 6411
2023
Q4 		$218 Sell
5
-336
-99% -$10.7K ﹤0.01% 6585
2023
Q3 		$10.6K Buy
341
+2
+0.6% +$75 ﹤0.01% 5794
2023
Q2 		$15.7K Buy
339
+1
+0.3% +$63 ﹤0.01% 5805
2023
Q1 		$13.2K Buy
338
+1
+0.3% +$56 ﹤0.01% 5765
2022
Q4 		$23.4K Buy
337
+335
+16,750% +$18.7K ﹤0.01% 5192
2022
Q3 		$0 Buy
2
+1
+100% +$67 ﹤0.01% 6970
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7117
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7409
2021
Q4 		$0 Hold
1
– – ﹤0.01% 7496
2021
Q3 		$0 Buy
+1
New +$249 ﹤0.01% 7223

Other funds holding INAB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Wells Fargo's INAB Position: Q2 2024 in Review

Wells Fargo sold out of IN8bio (INAB) in Q2 2024, closing a stake of 8 shares — an estimated $291 sold.

Wells Fargo first reported a position in INAB in Q3 2021 and held it in 11 quarters. The position peaked at $23.4K in Q4 2022. 26 funds tracked by Wall St. Rank hold INAB as of Q2 2024.

  • Wells Fargo reported no remaining IN8bio position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 8 IN8bio shares in Q2 2024, an estimated $291.
  • Wells Fargo first reported a position in IN8bio in Q3 2021 and held it in 11 quarters.
  • Wells Fargo's IN8bio position peaked at $23.4K in Q4 2022.
  • 26 funds tracked by Wall St. Rank held IN8bio as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.